R
Rxilient Health
Health Tech & Medtech · Singapore, Singapore · Founded 2019
Providing competitive healthcare solutions for unmet needs MoreLess
Rxilient Health is an open platform enterprise dedicated to linking pharmaceutical innovation with commercialization. The company focuses on improving disease care and clinical practices to benefit patients. Rxilient Health operates in the medical, health, and beauty sectors, providing competitive products and services to meet unmet clinical needs. The company builds a professional product matrix in dermatology and medical aesthetics, aiming to fulfill diverse skin health and aesthetic needs with a scientific mindset. Additionally, Rxilient Health identifies, develops, and commercializes urgently needed ophthalmic medicines and devices to enhance disease diagnosis and treatment, driving biotechnology breakthroughs in ophthalmology. In oncology, the company stringently selects global consumer health products to improve patient outcomes. Rxilient Health serves a broad range of clients, including healthcare providers, medical professionals, and patients, operating primarily in the pharmaceutical and medical device markets. The business model revolves around the development, commercialization, and lifecycle management of innovative medical products. Revenue is generated through the sale of these products and services, as well as through strategic partnerships and collaborations within the medical innovation ecosystem.
Keywords: pharmaceutical innovation, commercialization, dermatology, medical aesthetics, ophthalmology, oncology, disease care, biotechnology, lifecycle management, healthcare providers.
Company overview
Rxilient Health company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2019
- Headquarters
- Singapore, Singapore
- Employees
- 38
- Open positions
- 3
- Dealroom signal
- 55.5
Valuation & funding
Rxilient Health funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VC✓Equity / VC | Oct 2023 | $30M | $120M | Legend Capital · Pharmaron Holding · China Medical System Holdings | ↗ |
Financials
Workforce over time
Available workforce history. Financial fields without reported data are omitted.
| Year | Employees |
|---|---|
| 2026 | 38 |
| 2025 | 38 |
| 2024 | 35 |
| 2023 | 25 |
Growth signals
Rxilient Health website traffic
Latest recorded traffic for Rxilient Health is 5.5K monthly website visits, up 189.5% over the last three months. Rxilient Health's team grew 0% over the past year.
Hiring
Open positions at Rxilient Health
Current openings linked to this company in Dealroom.
Comparisons
Rxilient Health compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Rxilient Health's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Rxilient Health has talent and traffic
In the news
Latest news about Rxilient Health
Recent press, funding announcements, and product moves mentioning Rxilient Health — open to read from the original sources.
Market sentiment
What the market is saying about Rxilient Health
An AI-synthesized read of the highest-engagement posts about Rxilient Health on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Rxilient Health’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.